Show items per page
Elements: 113
Page 1 on 3
 TitleAuthors / EditorsDate
add to browser selection
When to initiate combined antiretroviral therapy to reduce mortality and AIDS-defining illness in HIV-infected persons in developed countries: an observational study Cain, Lauren E; Logan, Roger; Robins, James M; Sterne, Jonathan A C; ... Wyler, Claire-Anne 2011
add to browser selection
Viral resuppression and detection of drug resistance following interruption of a suppressive non-nucleoside reverse transcriptase inhibitor-based regimen Fox, Zoe; Phillips, Andrew; Cohen, Cal; Neuhaus, Jacquie; ... Lundgren, Jens 2008
add to browser selection
Turnover of CD4+ and CD8+ T lymphocytes in HIV-1 infection as measured by Ki-67 antigen Sachsenberg, N.; Perelson, A. S.; Yerly Ferrillo, Sabine; Schockmel, G. A.; ... Perrin, Luc 1998
add to browser selection
Treatment of psoriasis with alefacept in patients with hepatitis C infection: a report of two cases Thaci, Diamant; Patzold, S.; Kaufmann, Roland; Boehncke, Wolf-Henning 2005
add to browser selection
Treatment failure and mortality factors in patients receiving second-line HIV therapy in resource-limited countries Pujades-Rodriguez, Mar; Balkan, Suna; Arnould, Line; Brinkhof, Martin A. W.; Calmy, Alexandra 2010
add to browser selection
Treatment and prognosis of AIDS-related lymphoma in the era of highly active antiretroviral therapy: findings from the Swiss HIV Cohort Study Simcock, Mathew; Blasko, Monika; Karrer, Urs; Bertisch, Barbara; ... Koller, M. T. 2007
add to browser selection
Toxicity, efficacy, plasma drug concentrations and protease mutations in patients with advanced HIV infection treated with ritonavir plus saquinavir. Swiss HIV Cohort Study Lorenzi, P.; Yerly Ferrillo, Sabine; Abderrakim, K.; Fathi, Marc; ... Hirschel, Bernard 1997
add to browser selection
Time of initiation of antiretroviral therapy: impact on HIV-1 viraemia. The Swiss HIV Cohort Study Yerly Ferrillo, Sabine; Kaiser, Laurent; Perneger, T. V.; Cone, R. W.; ... Perrin, Luc 2000
add to browser selection
The role of compartment penetration in PI-monotherapy: the Atazanavir-Ritonavir Monomaintenance (ATARITMO) Trial Vernazza, Pietro; Daneel, Synove; Schiffer, Veronique; Decosterd, Laurent; ... Hirschel, Bernard 2007
add to browser selection
The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals Ray, Maile; Logan, Roger; Sterne, Jonathan A C; Hernández-Díaz, Sonia; ... Hernán, Miguel A 2010
add to browser selection
The CD4 cell count 3 months after acute retroviral syndrome is associated with the presence of AIDS in the source individual Vanhems, Philippe; Caillat-Vallet, Emmanuelle; Hirschel, Bernard; Routy, J. P.; ... Perrin, Luc 2002
add to browser selection
Switching from protease inhibitors to efavirenz: differences in efficacy and tolerance among risk groups: a case-control study from the Swiss HIV Cohort Hirschel, Bernard; Flepp, Markus; Bucher, H. C.; Zellweger, Claudine; ... Ledergerber, Bruno 2002
add to browser selection
Survival in 2367 zidovudine-treated patients according to use of other nucleoside analogue drugs. The EuroSIDA Study Group Phillips, A. N.; Katlama, C.; Barton, S.; Vella, S.; ... Lundgren, J. D. 1998
add to browser selection
Suicide in HIV-infected individuals and the general population in Switzerland, 1988-2008 Keiser, Olivia; Spoerri, Adrian; Brinkhof, Martin W. G.; Hasse, Barbara; ... Egger, Mathias 2010
add to browser selection
Subgroup analyses of maraviroc in previously treated R5 HIV-1 infection Fätkenheuer, Gerd; Nelson, Mark; Lazzarin, Adriano; Konourina, Irina; ... van der Ryst, Elna 2008
add to browser selection
Structured treatment interruptions in HIV infection: benefit or disappointment? Oxenius, Annette; Hirschel, Bernard 2003
add to browser selection
Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection Oxenius, Annette; Price, D. A.; Gunthard, Huldrych; Dawson, S. J.; ... Phillips, R. E. 2002
add to browser selection
Short-term clinical disease progression in HIV-1-positive patients taking combination antiretroviral therapy: the EuroSIDA risk-score Mocroft, Amanda; Ledergerber, Bruno; Zilmer, Kai; Kirk, Ole; ... Lundgren, J. D. 2007
add to browser selection
Salvage therapy with abacavir plus a non-nucleoside reverse transcriptase inhibitor and a protease inhibitor in heavily pre-treated HIV-1 infected patients. Swiss HIV Cohort Study Khanna, Nina; Klimkait, T.; Schiffer, V.; Irigoyen, J.; ... Battegay, M. 2000
add to browser selection
Ritonavir plus saquinavir versus single protease inhibitor therapy in protease inhibitor-naive HIV-infected patients: the Swiss HIV Cohort Study Bucher, H. C.; Bichsel, M.; Taffe, Patrick; Furrer, Hansjakob; ... Battegay, M. 2002
add to browser selection
Risk for opportunistic disease and death after reinitiating continuous antiretroviral therapy in patients with HIV previously receiving episodic therapy: a randomized trial El-Sadr, W. M.; Grund, B.; Neuhaus, J.; Babiker, A.; ... Neaton, J. D. 2008
add to browser selection
Risk factors for anal cancer in persons infected with HIV: a nested case-control study in the Swiss HIV Cohort Study Bertisch, Barbara; Franceschi, Silvia; Lise, Mauro; Vernazza, Pietro; ... Clifford, Gary 2013
add to browser selection
Rilpivirine use in the Swiss HIV cohort study: a prospective cohort study Sculier, Delphine; Gayet-Ageron, Angèle; Battegay, Manuel; Cavassini, Matthias; ... Calmy, Alexandra 2017
add to browser selection
Response to first protease inhibitor- and efavirenz-containing antiretroviral combination therapy. The Swiss HIV Cohort Study Friedl, A. C.; Ledergerber, Bruno; Flepp, Markus; Hirschel, Bernard; ... Weber, R. 2001
add to browser selection
Response to antiretroviral therapy among patients exposed to three classes of antiretrovirals: results from the EuroSIDA study Mocroft, A.; Phillips, A. N.; Friis-Moller, N.; Colebunders, R.; ... Lundgren, J. D. 2002
add to browser selection
Residual HIV-specific CD4 and CD8 T cell frequencies after prolonged antiretroviral therapy reflect pretreatment plasma virus load Oxenius, Annette; Price, D. A.; Dawson, S. J.; Gunthard, Huldrych; ... Phillips, R. E. 2002
add to browser selection
Relevance of HIV-1-specific CD4+ helper T-cell responses during structured treatment interruptions in patients with CD4+ T-cell nadir above 400/mm3 Plana, Montserrat; Garcia, Felipe; Oxenius, Annette; Ortiz, G. M.; ... Gatell, J. M. 2004
add to browser selection
Regression of Kaposi's sarcoma during therapy with HIV-1 protease inhibitors: a prospective pilot study Krischer, Joachim; Rutschmann, Olivier Thierry; Hirschel, Bernard; Vollenweider-Roten, S.; ... Pechere, Marc 1998
add to browser selection
Reducing tuberculosis incidence by tuberculin skin testing, preventive treatment, and antiretroviral therapy in an area of low tuberculosis transmission Elzi, Luigia; Schlegel, Matthias; Weber, Rainer; Hirschel, Bernard; ... Furrer, Hansjakob 2007
add to browser selection
Randomized controlled study demonstrating failure of LPV/r monotherapy in HIV: the role of compartment and CD4-nadir Gutmann, Christine; Cusini, Alexia; Gunthard, Huldrych F.; Fux, Christoph; ... Vernazza, Pietro L. 2010
add to browser selection
Prognostic value of viremia in patients with long-standing human immunodeficiency virus infection. Swiss HIV Cohort Study Group Galetto-Lacour, Annick; Yerly Ferrillo, Sabine; Perneger, T. V.; Baumberger, Christophe; ... Perrin, Luc 1996
add to browser selection
Preoperative counts of CD4 T-lymphocytes and early postoperative infective complications in HIV-positive patients Savioz, Daniel; Chilcott, Michael John; Ludwig, Corinna; Savioz, M; ... Morel, Philippe 1998
add to browser selection
Predictors of optimal viral suppression in patients switched to abacavir, lamivudine, and zidovudine: the Swiss HIV Cohort Study Wolbers, Marcel; Opravil, Milos; von Wyl, Viktor; Hirschel, Bernard; ... Bucher, H. C. 2007
add to browser selection
Predictive value of codon 215 reverse transcriptase mutation on the efficacy of didanosine in HIV-infected, zidovudine-experienced patients Yerly Ferrillo, Sabine; Denereaz, N.; Mermillod, Bernadette; Hirschel, Bernard; Perrin, Luc 1996
add to browser selection
Predicting the evolution of Kaposi sarcoma, in the highly active antiretroviral therapy era Boffi El Amari, Emmanuelle; Toutous-Trellu, Laurence; Gayet-Ageron, Angèle; Baumann, Michele; ... Hirschel, Bernard 2008
add to browser selection
Non-Hodgkin lymphoma incidence in the Swiss HIV Cohort Study before and after highly active antiretroviral therapy Polesel, Jerry; Clifford, Gary M.; Rickenbach, Martin; Dal Maso, Luigino; ... Franceschi, Silvia 2008
add to browser selection
Nadir CD4 count and monthly income predict cervical squamous cell abnormalities in HIV-positive women in a resource-limited setting Mangclaviraj, Somsamorn; Kerr, Stephen J.; Chaithongwongwatthana, Surasith; Ananworanich, Jintanat; ... Phanuphak, Praphan 2008
add to browser selection
Modeling the influence of APOC3, APOE, and TNF polymorphisms on the risk of antiretroviral therapy-associated lipid disorders Tarr, P. E.; Taffe, Patrick; Bleiber, Gabriela; Furrer, Hansjakob; ... Telenti, Amalio 2005
add to browser selection
Minor protease inhibitor mutations at baseline do not increase the risk for a virological failure in HIV-1 subtype B infected patients Scherrer, Alexandra U; Ledergerber, Bruno; von Wyl, Viktor; Böni, Jürg; ... Günthard, Huldrych F 2012
add to browser selection
Mean CD4 cell count changes in patients failing a first-line antiretroviral therapy in resource-limited settings Calmy, Alexandra; Balestre, Eric; Bonnet, Fabrice; Boulle, Andrew; ... Dabis, François 2012
add to browser selection
Management of resistant mucocutaneous herpes simplex infections in AIDS patients: a clinical and virological challenge Barde, C; Piguet, Vincent; Pechere, Marc; Masouyé, Isabelle; ... Toutous Trellu, Laurence Marie 2011
add to browser selection
Major clinical outcomes in antiretroviral therapy (ART)-naive participants and in those not receiving ART at baseline in the SMART study Emery, Stéphane; Neuhaus, J. A.; Phillips, A. N.; Babiker, A.; ... Wood, R. 2008
add to browser selection
Lung cancer in the Swiss HIV Cohort Study: role of smoking, immunodeficiency and pulmonary infection Clifford, G M; Lise, M; Franceschi, S; Egger, M; ... Schöni-Affolter, F 2012
add to browser selection
Longer term clinical and virological outcome of sub-Saharan African participants on antiretroviral treatment in the Swiss HIV Cohort Study Staehelin, Cornelia; Keiser, Olivia; Calmy, Alexandra; Weber, Rainer; ... Furrer, Hansjakob 2012
add to browser selection
Long-term safety and effectiveness of ritonavir, nelfinavir, and lopinavir/ritonavir in antiretroviral-experienced HIV-infected children Rudin, Christoph; Burri, Marcus; Shen, Yang; Rode, Richard; Nadal, David 2008
add to browser selection
Long-term safety and effectiveness of lopinavir/ritonavir in antiretroviral-experienced HIV-1-infected children Rudin, Christoph; Wolbers, Marcel; Nadal, David; Rickenbach, Martin; Bucher, Heiner C 2010
add to browser selection
Long-term efficacy, safety, and tolerability of indinavir-based therapy in protease inhibitor-naive adults with advanced HIV infection Hirsch, M. S.; Steigbigel, R. T.; Staszewski, Scholomo; McMahon, Deborah; ... Leavitt, R. Y. 2003
add to browser selection
Long-term efficacy and safety of first-line therapy with once-daily saquinavir/ritonavir Ananworanich, Jintanat; Gayet-Ageron, Angèle; Ruxrungtham, Kiat; Chetchotisakd, Ploenchan; ... Hirschel, Bernard 2008
add to browser selection
Liver enzyme elevation after lamivudine withdrawal in HIV-hepatitis B virus co-infected patients: the Swiss HIV Cohort Study Bellini, C.; Keiser, Olivia; Chave, J-P; Evison, Jm; ... Cavassini, M. 2009
add to browser selection
Late presentation of HIV-infected individuals Battegay, Manuel; Fluckiger, Ursula; Hirschel, Bernard; Furrer, Hansjakob 2007
<< previous | 1 | 2 | 3 |